A New Jersey couple has filed a Biomet M2a Magnum lawsuit claiming that the wife’s metal-on-metal hip replacement resulted in severe complications.

Plaintiffs Maureen B. and Charles B. allege that Biomet is responsible for manufacturing, marketing and selling a defective device.

According to this Biomet M2a Magnum lawsuit, Maureen received a total left hip arthroplasty on March 12, 2006 and then two years later, a right hip arthroplasty on Feb. 1, 2008 with the Biomet M2a Magnum device.

The plaintiffs claim that agents of Biomet aggressively marketed their Biomet M2a Magnum device to doctors who perform hip arthroplasties, including Maureen’s surgeon.

This Biomet M2a Magnum lawsuit claims that Biomet “assured the orthopedic surgeons, including [the] plaintiff’s orthopedic surgeon, that the M2a Magnum Hip System was safe, effective, was the best product on the market, had an excellent track record, would last longer than traditional hip implants and had a low acceptable failure rate.”

She claims that after she was implanted with the Biomet M2a Magnum device, she suffered from increasingly debilitating pain, discomfort, soreness, dysfunction and loss of range of motion.

But it wasn’t until 2015 that doctors discovered significantly elevated levels of cobalt and chromium in Maureen’s bloodstream, she claims.

Because of this, Maureen underwent a hip revision surgery to replace her right hip system. She claims that because of the defective Biomet M2a Magnum device that was initially implanted, she was forced to undergo this risky additional surgery.

The plaintiffs in this Biomet M2a Magnum lawsuit believe that as a direct and proximate result of this hip system, Maureen “has suffered and will continue to suffer great pain and suffering, was and is incapacitated, and was caused to seek and in the future will be caused to seek medical and hospital treatment, and was permanently injured.”

She alleges she has suffered from pain, swelling, inflammation, and damage to the bone and tissue around her implant site. Maureen claims that this is because of loosening of the implant, a condition in which the implant pulls away from the bone and hip socket.

She also alleges the device caused fracture and dislocation. Fracture, in this context, is when the bone around the implant breaks and dislocation refers to when parts of the implant are no longer aligned correctly.

What allegedly caused the elevated metal in Maureen’s blood what the spread of metal debris in the surrounding tissue because the metal components constantly rub on one another.

The two plaintiffs in this lawsuit are claiming that Biomet is responsible for design defect, failure to warn, breach of express warranty, violation of state consumer protection law, negligence, negligent misrepresentation, breach of implied warranty and loss of consortium.

This Biomet M2a Magnum Lawsuit is Case No. 3:17-cv-00417-RLM-MGG, in the Superior Court of New Jersey, Monmouth County.